N-hydroxyurea and acyl nitroso compounds as nitroxyl (HNO) and nitric oxide (NO) donors

Current Topics in Medicinal Chemistry

Volumn 5, Issue 7, 2005, Pages 665-673

  King, S Bruce ^a  

^a WAKE FOREST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; CATALASE; HEMOGLOBIN; HEMOPROTEIN; HORSERADISH PEROXIDASE; HYDROXYLAMINE; HYDROXYUREA; IRON COMPLEX; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROSO DERIVATIVE; UREASE;

CATALYSIS; CLINICAL OBSERVATION; COMPLEX FORMATION; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG METABOLISM; DRUG OXIDATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; IN VIVO STUDY; REVIEW; SICKLE CELL ANEMIA;

ANIMALS; HUMANS; HYDROXYUREA; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGEN OXIDES; NITROSO COMPOUNDS;

EID: 23844494816     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026054679362     Document Type: Review

References (76)

1. Donchower, R. C. Hydroxyurea. In Cancer Chemotherapy and Biotherapy; B. A. Chabner and D. L. Longo, Eds.; Lippincott-Raven; Philadelphia, 1996; pp. 253-261.
2. Liermann, B.; Lassmann, G.; Langen, P. Quenching of Tyrosine Radicals of M2 Subunit From Ribonucleotide Reductase in Tumor Cells by Different Antitumor Agents: An EPR Study. Free Radical Biol. Med. 1990, 9, 1-4.
3. Lori, F.; Malykh, A.; Cara, A.; Sun, D.; Weinstein, J.N.; Lisziewicz, J.; Gallo, R.C. Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type I Replication. Science 1994, 266, 801-805.
4. Steinberg, M. H.; Barton, F.; Castro, O.; Pegelow, C. H.; Ballas, S. K.; Kutlar, A.; Orringer, E.; Bellevue, R..; Olivieri, N.; Eckman, J.; Varmo, M.; Ramirez, G.; Adler, B.; Smith, W.; Carlos, T.; Ataga, K.; DeCastro, L.; Bigelow, C.; Saunthararajah, Y.; Telfer, M.; Vichinsky, E.; Claster, S.; Shurin, S.; Bridges, K.; Waclawiw, M.; Bonds, D.; Terrin, M. Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits up to 9 Years of Treatment. JAMA 2003, 289, 1645-1651.
5. Charache, S.; Terrin, M. L.; Moore, R. D.; Dover, G. J.; Barton, F. B.; Eckert, S. V.; McMahon, R. P.; Bonds, D. R. and the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia. N. Engl. J. Med. 1995, 332, 1317-1322.
6. Charache, S.; Barton, F. B.; Moore, R. D.; Terrin, M. L.; Steinberg, M. H.; Dover, G. J.; Ballas, S. K.; McMahon, P.; Castro, O.; Orringer, E. P and the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Hydroxyurea and Sickle Cell Anemia. Med. 1996, 75, 300-326.
7. Halsey, C.; Roberts, I. A. G. The Role of Hydroxyurea in Sickle Cell Disease. Brit. J. Haematol. 2003, 120, 177-186.
8. King, S. B. The Nitric Oxide Producing Reactions of Hydroxyurea. Curr. Med. Chem. 2003, 10, 437-452.
9. Reiter, C. D.; Gladwin, M. T. An Emerging Role for Nitric Oxide in Sickle Cell Disease Vascular Homeostasis and Therapy. Curr. Opin. Hematol. 2003, 10, 99-107.
10. Gladwin, M. T.; Schechter, A. N. Nitric Oxide Therapy in Sickle Cell Disease. Seminars in Hematology, 2001, 38(No. 4), 333-342.
11. Reiter, C. D.; Wang, X.; Tanus-Santos, J. E.; Hogg, N.; Cannon, R. O.; Schechter, A. N.; Gladwin, M. T. Cell-Free Hemoglobin Limits Nitric Oxide Bioavailability in Sickle Cell Disease. Nature Med. 2002, 8, 1383-1389.
12. Aslan, M.; Ryan, T. M.; Adler, B.; Townes, T. M.; Parks, D. A.; Thompson, J. A.; Tousson, A.; Gladwin, M. T.; Patel, R. P.; Tarpey, M. M.; Batinic-Haberle, I.; White, R. C.; Freeman, B. A. Oxygen Radical Inhibition of Nitric Oxide-Dependent Vascular Function in Sickle Cell Disease. Proc. Natl. Acad. Sci. 2001, 98, 15215-15220.
13. Aslan, M.; Ryan, T. M.; Townes, T. M.; Coward, L.; Kirk, M. C.; Barnes, S.; Alexander, C. B.; Rosenfeld, S. S.; Freeman, B. A. Nitric Oxide-Dependent Generation of Reactive Species in Sickle Cell Disease. J. Biol. Chem. 2003, 278, 4194-4204.
14. Ikuta, T.; Ausenda, S.; Cappellini, M. D. Mechanism for Fetal Globin Gene Expression: Role of the Soluble Guanylate Cyclase-cGMP-dependent Protein Kinase Pathway. Proc. Natl. Acad. Sci. 2001, 98, 1847-1852.
15. Cokic, V. P.; Smith, R. D.; Beleslin-Cokic, B. B.; Njoroge, J. M.; Miller, J. L.; Gladwin, M. T.; Schechter, A. N. Hydroxyurea Induces Fetal Hemoglobin by the Nitric Oxide-Dependent Activation of Soluble Guanylyl Cyclase. J. Clin. Invest. 2003, 111, 231-239.
16. Nahavandi, M.; Tavakkoli, F.; Wyche, M. Q.; Perlin, E.; Winter, W. P.; Castro, O. Nitric Oxide and Cyclic GMP Levels in Sickle Cell Patients Receiving Hydroxyurea. Brit. J. Haematol. 2002, 119, 855-857.
17. Conran, N.; Oresco-Santos, C.; Acosta, H. C.; Fattori, A.; Saad, S. T. O.; Costa, F. F. Increased Soluble Guanylate Cyclase Activity in the Red Blood Cells of Sickle Cell Patients. Brit. J. Haematol. 2003, 124, 547-554.
18. Ho, J. A.; Pickens, C. V.; Gamscik, M. P.; Colvin, O. M.; Ware, R. E. In Vitro Induction of Fetal Hemoglobin in Human Erythroid Progenitor Cells. Exp. Hematol. 2003, 31, 586-591.
19. Lepoivre, M.; Flaman, J. M.; Bobe, P.; Lemari, G.; Henry, Y. Quenching of the Tyrosyl Free Radical of Ribonucleotide Reductase by Nitric Oxide. J. Biol. Chem. 1994, 269, 21891-21897.
20. Gwilt, P. R.; Tracewell, W. G. Pharmacokinetics and Pharmacodynamics of Hydroxyurea. Clin. Pharmacokinet. 1998, 34, 347-356.
21. Tracewell, W. G.; Trump, D. L.; Vaughn, W. P.; Smith, D. C.; Gwilt, P. R. Population Pharmacokinetics of Hydroxyurea in Cancer Patients. Cancer Chemother. Pharmacol. 1995, 35, 417-422.
22. Colvin, M.; Bono, Jr., V. H. The Enzymatic Reduction of Hydroxyurea to Urea by Mouse Liver. Cancer Res. 1970, 30, 1516-1519.
23. 14C. J. Pharmcol. Exp. Ther. 1965, 150, 322-327.
24. Bernheim, M. L. C. Metabolism of Anthranilic Hydroxamic Acid by Rat Liver. Arch. Biochem. Biophys. 1965, 112, 191-195.
25. Sugihara, K.; Kitamura, S.; Ohta, S.; Tatsumi, K. Reduction of Hydroxamic Acids to the Corresponding Amides Catalyzed by Rabbit Blood. Xenobiotica, 2000, 30, 457-467.
26. Boyland, E.; Nery, R. The Metabolism of Urethane and Related Compounds. Biochem. J. 1965, 94, 198-208.
27. Nery, R. Some Aspects of the Metabolism of Urethane and N-Hydroxyurethane. Biochem. J. 1968, 106, 1-13.
28. Fishbein, W. N.;Winter, T. S.; Davidson, J. D. Urease Catalysis: Stoichiometry, Specificity, and Kinetics of a Second Substrate, Hydroxyurea. J. Biol. Chem. 1965, 240, 2402-2406.
29. Fishbein, W. N.; Carbone, P. P. Urease Catalysis: Inhibition of the Enzyme by Hydroxyurea, Hydroxylamine, and Acetohydroxamic Acid. J. Biol. Chem. 1965, 240, 2407-2414.
30. Stolze, K.; Nohl, H. Detection of Free Radicals as Intermediates in the Methemoglobin Formation from Oxyhemoglobin Induced by Hydroxylamine. Biochem. Pharmacol. 1989, 38, 3055-3059.
31. Taira, J.; Misik, V.; Riesz, P. Nitric Oxide Formation from Hydroxylamine by Myoglobin and Hydrogen Peroxide. Biochim. Biophys. Acta 1997, 1336, 502-508.
32. Wang, P. G.; Xian, M.; Tang, X.; Wu, X.; Wen, Z.; Cai, T.; Janczuk, A. J. Nitric Oxide Donors: Chemical Activities and Biological Applications. Chem. Rev. 2002, 102, 1091-1134.
33. Fishbein, W. N.; Carbone, P. P. Hydroxyurea: Mechanism of Action. Science 1963, 142, 1069-1070.
34. Bernheim, M. L, C. The Enzymatic Hydrolysis of Certain Hydroxamic Acids. Arch. Biochem. Biophys. 1964, 107, 313-318.
35. Jiang, J.; Jordan, S. J.; Barr, D. P.; Gunther, M. R.; Maeda, H.; Mason, R. P. In Vivo Production of Nitric Oxide in Rats after Administration of Hydroxyurea. Mol. Pharmacology 1997, 52, 1081-1086.
36. Glover, R. E.; Ivy, E. D.; Orringer, E. P.; Maeda, H.; Mason, R. P. Detection of Nitrosyl Hemoglobin in Venous Blood in the Treatment of Sickle Cell Anemia with Hydroxyurea. Mol. Pharmacology 1999, 55, 1006-1010.
37. Gladwin, M. T.; Shelhamer, J. H.; Ognibene, F. P.; Pease-Fye, M. E., Nichols, J. S.; Link, B.; Patel, D. B.; Jankowski, M. A.; Pannell, L. K.; Schechter, A. N.; Rodgers, G. P. Nitric Oxide Donor Properties of Hydroxyurea in Patients with Sickle Cell Disease. Brit. J. Haematol. 2002, 116, 436-444.
38. 2 Reaction. Chem. Res. Toxicol. 1993, 6, 23-27.
39. Morris, C. R.; Vichinsky, E. P.; van Warmerdam, J.; Machado, L.; Kepka-Lenhart, D.; Morris, S. M.; Kuypers, F. A. Hydroxyurea and Arginine Therapy: Impact on Nitric Oxide Production in Sickle Cell Disease. J. of Pediatric Hematology/Oncology 2003, 25, 629-634.
40. Sakano, K.; Oikawa, S.; Hasegawa, K.; Kawanishi, S. Hydroxyurea Induces Site-Specific DNA Damage via Formation of Hydrogen Peroxide and Nitric Oxide. Jpn. J. Cancer Res. 2001, 92, 1166-1174.
41. Pacelli, R; Taira, J.; Cook, J. A.; Wink, D. A.; Krishna, M. C. Hydroxyurea Reacts with Heme Proteins to Generate Nitric Oxide. Lancet 1996, 347, 900.
42. Xu, Y.; Mull, C. D.; Bonifant, C. L.; Yasaki, G.; Palmer, E. C.; Shields, H.; Ballas, S. K.; Kim-Shapiro, D. B.; King, S. B. Nitrosylation of Sickle Cell Hemoglobin by Hydroxyurea. J. Org. Chem. 1998, 63, 6452-6453.
43. Huang, J.; Hadimani, S. B.; Rupon, J. W.; Ballas, S. K.; Kim-Shapiro, D. B.; King, S. B. Iron Nitrosyl Hemoglobin Formation from the Reactions of Hydroxyurea and Hemoglobin. Biochemistry 2002, 41, 2466-2474.
44. King, S. B. Nitric Oxide Production from Hydroxyurea. Free. Rad. Biol. Med. 2004, 37, 737-744.
45. Huang, J.; Zou, Z.; Kim-Shapiro, D. B.; Ballas, S. K.; King, S. B. Hydroxyurea Analogs as Kinetic and Mechanistic Probes of the Nitric Oxide Producing Reactions of Hydroxyurea and Oxyhemoglobin. J. Med. Chem. 2003, 46, 3748-3753.
46. Stolze, K.; Nohl, H. EPR Studies on the Oxidation of Hydroxyurea to Paramagnetic Compounds by Oxyhemoglobins. Biochem. Pharmacol. 1990, 40, 799-802.
47. Kim-Shapiro, D. B.; King, S. B.; Bonifant C. L.; Kolibash, C. P.; Ballas, S. K. Time Resolved Absorption Study of the Reaction of Hydroxyurea with Sickle Cell Hemoglobin. Biochimica et Bio-physica Acta 1998, 1380, 64-74.
48. Kim-Shapiro, D. B.; King, S. B.; Shields, H.; Kolibash, C. P.; Gravatt, L.; Ballas, S. K. The Reaction of Deoxy-Sickle Cell Hemoglobin with Hydroxyurea. Biochimica et Biophysica Acta 1999, 1428, 381-387.
49. Rupon, J. W.; Domingo, S. R.; Smith, S. V.; Gummadi, B. K.; Shields, H.; Ballas, S. K.; King, S. B.; Kim-Shapiro, D, B. The Reactions of Myoglobin, Normal Adult Hemoglobin, Sickle Cell Hemoglobin and Hemin with Hydroxyurea. Biophysical Chem. 2000, 84, 1-11.
50. Huang, J.; Sommers, E.; Kim-Shapiro, D. B.; King, S. B. Horseradish Peroxidase Catalyzed Nitric Oxide Formation from Hydroxyurea. J. Am. Chem. Soc. 2002, 124, 3473-3480.
51. Doyle, M. P.; Mahapatro, S. N.; Broene, R. D.; Guy, J. K. Oxidation and Reduction of Hemoproteins by Trioxodinitrate (II). The Role of Nitrosyl Hydride and Nitrite. J. Am. Chem. Soc. 1988, 110, 593-599.
52. Bazylinski, D. A.; Goretski, J.; Hollocher, T. C. On the Reaction of Trioxodinitrate (II) with Hemoglobin and Myoglobin. J. Am. Chem. Soc. 1985, 107, 7986-7989.
53. Bazylinksi, D. A.; Hollocher, T. C. Metmyoglobin and Methemoglobin as Efficient Traps for Nitrosyl Hydride (Nitroxyl) in Neutral Aqueous Solutions. J. Am. Chem. Soc. 1985, 107, 7982-7986.
54. Miranda, K. M.; Nims, R. W.; Thomas, D. D.; Espey, M. G.; Citrin, D.; Bartberger, M. D.; Paolocci, N.; Fukuto, J. M.; Feelisch, M.; Wink, D. A. Comparison of the Reactivity of Nitric Oxide and Nitroxyl with Heme Proteins: A Chemical Discussion of the Differential Biological Effects of these Redox Related Products of NOS. J. Inog. Biochem. 2003, 93, 52-60.
55. Akaike, T.; Maeda, H. In Methods in Enzymology, Volume 268, Nitric Oxide Part A: Sources and Detection of NO; NO Synthase; Packer, L. Ed.; Academic Press: San Diego, 1996; Chapter 20.
56. Glover, R. E.; Koshkin, V.; Dunford, H. B.; Mason, R. P. The Reaction Rates of NO with Horseradish Peroxidase Compounds I and II. Nitric Oxide Biol. Chem. 1999, 3, 439-444.
57. Huang, J.; Kim-Shapiro, D. B.; King, S. B. Catalase-Mediated Nitric Oxide Formation From Hydroxyurea. J. Med. Chem. 2004, 47, 3495-3501.
58. Cooper, C. E. Nitric Oxide and Iron Proteins. Biochim. Biophys. Acta 1999, 1411, 290-309.
59. Christie, C. C.; Kirby, G. W.; McGuigan, H.; Mackinnon, J. W. M. C-Nitrosoformamides, a New Class of Transient Dienophiles Formed by Oxidation of N-Hydroxyureas. J. Chem. Soc. Perkin Trans. 1985, 2469-2473.
60. Jenkins, N.E.; Ware, Jr., R.W.; Atkinson, R.N.; King, S.B. Generation of Acyl Nitroso Compounds by the Oxidation of N-Acyl Hydroxylamines with the Dess Martin Periodinane Synthetic Commun. 2000, 30, 947-953.
61. Xu, Y.; Alavanja, M.M.; Johnson, V.L.; Yasaki, G.; King, S.B. Production of Nitroxyl (HNO) at Biologically Relevant Temperatures from the retro-Diels Alder Reaction of N-Hydroxyurea Derived Acyl Nitroso-9, 10-Dimethylantrhacene Cycloadducts. Tetrahedron Lett. 2000, 41, 4265-4269.
62. Zeng, B.; Huang, J.; Wright, M. W.; King, S. B. Nitroxyl (HNO) Release from New Functionalized N-Hydroxyurea Derived Acyl Nitroso-9, 10-Dimethylanthracene Cycloadducts. Bioorg. Med. Chem. Lett. 2004, 14, 5565-5568.
63. O'Bannon, P. E.; Sulzle, D.; Dailey, W. P.; Schwarz, H. Spectroscopic Detection of 2 Neutral Chno2 Isomers - Nitrocarbene and Nitrosoformaldehyde. J. Am. Chem. Soc. 1992, 114, 344-345.
64. O'Bannon, P. E.; Sulzle, D.; Schwarz, H. Characterization of Nitrosocarbonyl Compounds by Neutralization-Reionization Mass-Spectrometry. Helv. Chim. Acta 1991, 74, 2068-2074.
65. Cohen, A. D.; Zeng, B.; King, S. B.; Toscano, J. P. Direct Observation of an Acyl Nitroso Species in Solution by Time-Resolved IR Spectroscopy. J. Am. Chem. Soc. 2003, 125, 1444-1445.
66. Quadrelli, P.; Invernizzi, A. G.; Falzoni, M.; Caramella, P. Cycloadditions of nitrile oxides to amidoximes. A General Synthesis of 3,5-disubstituted 1,2,4-oxadiazole-4-oxides. Tetrahedron 1997, 53, 1787-1796.
67. Quadrelli, P.; Invernizzi, A. G.; Caramella, P. A Mild Oxidation of Nitrile Oxides: A New Synthetic Route to Nitroso Carbonyl Intermediates. Tetrahedron Lett. 1996, 37, 1909-1912.
68. Quadrelli, P.; Mella, M.; Invernizzi, A. G.; Caramella, P. The Mild Oxidation of Nitrile Oxides affords a Convenient Entry to Nitrosocarbonyl Intermediates, Versatile Tools in Organic Syntheses. Tetrahedron 1999, 55, 10497-10510.
69. Fukuto, J. M.; Hszieh, R.; Gulati, P.; Chiang, K. T.; Nagasawa, H. T. N,O-Diacylated-N-Hydroxyarylsulfonamides - Nitroxyl Precursors with Potent Smooth-Muscle Relaxant Properties. Biochem. Biophys. Res. Commun. 1992, 187, 1367-1373.
70. Lee, M. J. C.; Nagasawa, H. T.; Elberling, J. A.; Demaster, E. G. Prodrugs of Nitroxyl as Inhibitors of Aldehyde Dehydrogenase. J. Med. Chem. 1992, 35, 3648-3652.
71. Nagasawa, H. T.; Kawle, S. P.; Elberling, J. A.; Demaster, E. G.; Fukuto, J. M. Prodrugs of Nitroxyl as Potential Aldehyde Dehydrogenase Inhibitors Vis-a-Vis Vascular Smooth-Muscle Relaxants. J. Med. Chem. 1995, 38, 1865-1871.
72. Kofod, H. On the Isomerism of Hydroxyurea. VI. Paper-Partition Chromatography. Acta Chem. Scand. 1955, 9, 1575-1586.
73. Kofod, H.; Huang, T. Y. On the Isomerism of Hydroxyurea. III. Some Physical Properties of the Isomers. Acta Chem. Scand. 1954, 8, 485-493.
74. Parker, G. R.; Moore, E. C. Solvent Dependent Conformational System of Hydroxyureas in Octanol-Water and in Inhibition of Ribonucleotide Reductase. J. Pharm. Sci. 1977, 66, 1040-1044.
75. Lockamy, V. L.; Huang, J.; Shields, H.; Ballas, S. K.; King, S. B.; Kim-Shapiro, D. B. Urease Enhances the Formation of Iron Nitrosyl Hemoglobin in the Presence of Hydroxyurea. Biochimica et Biophysica Acta 2003, 1622, 109-116.
76. Lockamy, V. L.; Shields, H.; Kim-Shapiro, D. B.; King, S. B. "Iron Nitrosyl Hemoglobin Formation from the Reaction of Hydroxylamine and Hemoglobin under Physiological Conditions". Biochimica et Biophysica Acta 2004, 1674, 260-267.